RGAS001-2 Gastric cancer organoid

Cat. #160931

RGAS001-2 Gastric cancer organoid

Cat. #: 160931

Sub-type: Organoids

Unit size: 40-100 uL of cell pellet/vial, 1ml

Organism: Human

Tissue: Gastric


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Medical-Industrial Translational Research Center

Institute: Fukushima Medical University

Tool Details
Application Details

Tool Details


  • Tool name: RGAS001-2 Gastric cancer organoid
  • Alternate name: RGAS001-2, RGAS1-2, RGAS1, RGAS001
  • Cancer: Digestive/Gastrointestinal cancer
  • Cancers detailed: Endocrine carcinoma;Gastric;Well differentiated Tubular adenocarcinoma (tub1)
  • Research fields: Cancer
  • Tool sub type: Organoids
  • Organism: Human
  • Tissue: Gastric
  • Gender: Female
  • Growth properties: Suspension
  • Application: 3D cell culture, High-throughput screening
  • Description: A series of novel patient-derived organoids (PDOs) have been constructed from different tumor tissue types under the Fukushima Translational Research Project, designated as F-PDO. F-PDOs form large cell clusters with a morphology similar to the original tumor and can be cultured for more than six months. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of F-PDOs were similar to their source tumors, even after long-term growth in culture conditions
  • Biosafety level: 1


  • Format: Frozen
  • Passage number: 5
  • Growth medium: Cancer Cell Expansion Media plus (Fujifilm Wako Pure Chemical, Ltd.) with 10 ng/mL bFGF and 10 ng/mL Activin A.
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Volume: 1 ml
  • Storage medium: CELLBANKER 2
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Pathogen and stelility test; Comprehensive gene expression analysis; Cancer panel sequencing; Whole exome sequencing; Anticancer drug susceptibility testing
  • Mycoplasma free: Yes
  • Biosafety level: 1

Application Details

  • Application: 3D cell culture, High-throughput screening